# Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

> **NCT00248547** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 40 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** aprepitant
- **DRUG:** dexamethasone
- **DRUG:** ondansetron
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00248547
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248547, "Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00248547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*